These compounds may interact with:
5-hydroxytryptamine receptor 1B
Potentially involved in: opiate dependence; carcinoma; migraine; obsessive-compulsive disorder; attention deficit hyperactivity disorder; alcohol dependence; major depressive disorder; personality disorder; schizophrenia; substance abuse; cocaine dependence; ischemic colitis; alcoholic intoxication, chronic; autistic disorder; bipolar disorder; cocaine abuse; mental depression; depressive disorder; hypotension; psychotic disorders
Disease data sourced from Pharos.